Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Celsius Holdings
CELH
$7.22B
| $1.39M | ﹤0.01% |
63,750
-39,645
| -38% | -$764K |
|
|
PPBI
2052
DELISTED
Pacific Premier Bancorp
PPBI
| $1.39M | ﹤0.01% |
47,398
-119,161
| -72% | -$3.81M |
|
2053
Crocs
CROX
$6.47B
| $1.38M | ﹤0.01% |
28,414
-107,125
| -79% | -$6.5M |
|
2054
CALL
Hilton Worldwide
HLT
$70.7B
| $1.38M | ﹤0.01% |
+12,400
| New | +$1.72M |
|
2055
OPAL Fuels
OPAL
$70.1M
| $1.38M | ﹤0.01% |
138,941
-58,319
| -30% | -$578K |
|
2056
UiPath
PATH
$6.76B
| $1.38M | ﹤0.01% |
75,925
-176,457
| -70% | -$3.3M |
|
|
SLAM
2057
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $1.38M | ﹤0.01% |
140,263
-25,716
| -15% | -$252K |
|
|
CIM
2058
Chimera Investment
CIM
$1.06B
| $1.38M | ﹤0.01% |
52,066
-23,322
| -31% | -$692K |
|
2059
Pediatrix Medical
MD
$2.16B
| $1.38M | ﹤0.01% |
65,486
-1,323
| -2% | -$27K |
|
|
ZVSA
2060
DELISTED
ZyVersa Therapeutics
ZVSA
| $1.38M | ﹤0.01% |
+396
| New | +$1.38M |
|
2061
Nelnet
NNI
$4.97B
| $1.38M | ﹤0.01% |
16,137
+3,498
| +28% | +$291K |
|
|
CFIV
2062
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $1.37M | ﹤0.01% |
139,214
| – | – |
|
|
TIPD
2063
DELISTED
Direxion Daily TIPS Bear 2X Shares
TIPD
| $1.36M | ﹤0.01% |
+50,000
| New | +$1.29M |
|
2064
Innoviva
INVA
$1.53B
| $1.36M | ﹤0.01% |
92,067
+14,592
| +19% | +$239K |
|
|
BIG
2065
DELISTED
Big Lots, Inc.
BIG
| $1.36M | ﹤0.01% |
64,749
-144,413
| -69% | -$4.25M |
|
|
ACH
2066
Accendra Health
ACH
$261M
| $1.36M | ﹤0.01% |
43,142
-28,815
| -40% | -$1.04M |
|
|
VSAC
2067
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
| $1.35M | ﹤0.01% |
135,204
| – | – |
|
2068
MYR Group
MYRG
$5.26B
| $1.35M | ﹤0.01% |
15,337
-8,985
| -37% | -$787K |
|
2069
Urban One Class D
UONEK
$22.8M
| $1.35M | ﹤0.01% |
31,560
-48,020
| -60% | -$2.8M |
|
2070
Riot Platforms
RIOT
$8.1B
| $1.35M | ﹤0.01% |
321,486
-26,995
| -8% | -$251K |
|
2071
Qualys
QLYS
$5.45B
| $1.35M | ﹤0.01% |
10,679
+348
| +3% | +$45.6K |
|
2072
Sonoco
SON
$5.58B
| $1.34M | ﹤0.01% |
23,578
+15,019
| +175% | +$893K |
|
2073
Citi Trends
CTRN
$582M
| $1.34M | ﹤0.01% |
56,805
+51,271
| +926% | +$1.45M |
|
2074
M/I Homes
MHO
$3.75B
| $1.34M | ﹤0.01% |
33,776
-22,527
| -40% | -$979K |
|
2075
Rackspace Technology
RXT
$1.21B
| $1.34M | ﹤0.01% |
186,308
+12,701
| +7% | +$115K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.